FI974434A0 - Trisyklisiä 5,6-dihydro-9H-pyratsolo(3,4-c)-1,2,4,-triatsolo(4,3-alfapidiinejä - Google Patents

Trisyklisiä 5,6-dihydro-9H-pyratsolo(3,4-c)-1,2,4,-triatsolo(4,3-alfapidiinejä

Info

Publication number
FI974434A0
FI974434A0 FI974434A FI974434A FI974434A0 FI 974434 A0 FI974434 A0 FI 974434A0 FI 974434 A FI974434 A FI 974434A FI 974434 A FI974434 A FI 974434A FI 974434 A0 FI974434 A0 FI 974434A0
Authority
FI
Finland
Prior art keywords
alphapyridines
triazolo
pyrazolo
tricyclic
dihydro
Prior art date
Application number
FI974434A
Other languages
English (en)
Swedish (sv)
Other versions
FI974434A (fi
FI114097B (fi
Inventor
Allen Jacob Duplantier
Kelvin Cooper
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI974434A0 publication Critical patent/FI974434A0/fi
Publication of FI974434A publication Critical patent/FI974434A/fi
Application granted granted Critical
Publication of FI114097B publication Critical patent/FI114097B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI974434A 1995-06-06 1997-12-05 Trisyklisiä 5,6-dihydro-9H-pyratsolo[3,4-c]-1,2,4-triatsolo[4,3-alfa]pyridiinejä FI114097B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IB9500429 1995-06-06
CA002223624A CA2223624C (en) 1995-06-06 1995-06-06 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines
CA2223624 1995-06-06
PCT/IB1995/000429 WO1996039408A1 (en) 1995-06-06 1995-06-06 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES
HU9601541 1996-06-05
HU9601541A HUP9601541A3 (en) 1995-06-06 1996-06-05 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolol[4,3-a]-pyridines and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
FI974434A0 true FI974434A0 (fi) 1997-12-05
FI974434A FI974434A (fi) 1997-12-05
FI114097B FI114097B (fi) 2004-08-13

Family

ID=89994031

Family Applications (1)

Application Number Title Priority Date Filing Date
FI974434A FI114097B (fi) 1995-06-06 1997-12-05 Trisyklisiä 5,6-dihydro-9H-pyratsolo[3,4-c]-1,2,4-triatsolo[4,3-alfa]pyridiinejä

Country Status (43)

Country Link
US (1) US6004974A (fi)
EP (1) EP0837860B1 (fi)
JP (1) JP3107827B2 (fi)
KR (2) KR100191972B1 (fi)
CN (1) CN1061044C (fi)
AP (1) AP609A (fi)
AR (1) AR002745A1 (fi)
AT (1) ATE214700T1 (fi)
AU (1) AU694871B2 (fi)
BG (1) BG62568B1 (fi)
BR (1) BR9602627A (fi)
CA (1) CA2223624C (fi)
CO (1) CO4700460A1 (fi)
CZ (1) CZ287251B6 (fi)
DE (1) DE69525978T2 (fi)
DK (1) DK0837860T3 (fi)
DZ (1) DZ2044A1 (fi)
ES (1) ES2172583T3 (fi)
FI (1) FI114097B (fi)
HR (1) HRP960268B1 (fi)
HU (1) HUP9601541A3 (fi)
IL (1) IL118485A (fi)
IS (1) IS1913B (fi)
LV (1) LV11620B (fi)
MA (1) MA23893A1 (fi)
MX (1) MX9709897A (fi)
MY (1) MY116527A (fi)
NO (1) NO306256B1 (fi)
NZ (1) NZ286734A (fi)
OA (1) OA10458A (fi)
PL (1) PL184195B1 (fi)
PT (1) PT837860E (fi)
RO (1) RO115881B1 (fi)
RU (1) RU2161158C2 (fi)
SA (1) SA96170065B1 (fi)
SG (1) SG54341A1 (fi)
SI (1) SI9600186A (fi)
SK (1) SK282167B6 (fi)
TN (1) TNSN96083A1 (fi)
TR (1) TR199600482A1 (fi)
TW (1) TW460469B (fi)
WO (1) WO1996039408A1 (fi)
YU (1) YU49346B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792938B1 (fr) * 1999-04-28 2001-07-06 Warner Lambert Co NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
US6326495B2 (en) 1999-04-30 2001-12-04 Pfizer Inc. Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
EP1380585B1 (en) * 1999-04-30 2004-11-10 Pfizer Products Inc. Pyrazolopyridinone as intermediate
MXPA02001830A (es) 1999-08-21 2002-08-12 Byk Gulden Lomberg Chem Fab Combinacion sinergica de inhibidores de pde y agonista de beta 2 adrenoceptor.
CA2402384A1 (en) * 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Benzylated pde4 inhibitors
ES2276942T3 (es) * 2001-05-25 2007-07-01 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG Combinacion de un inhibidor de pde4 y tiotropio o un derivado del mismo para tratar vias respiratorias obstructivas y otras enfermedades inflamatorias.
NZ529335A (en) * 2001-05-25 2005-09-30 Pfizer A PDE 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases
GB0122031D0 (en) * 2001-09-12 2001-10-31 Pfizer Ltd Use of pde4 inhibitors in a dry powder inhaler
GB0129395D0 (en) * 2001-12-07 2002-01-30 Pfizer Ltd Pharmaceutical combination
US20050107420A1 (en) * 2002-05-23 2005-05-19 Boehringe Ingelheim Pharma Gmbh & Co. Kg Combination of a PDE4 inhibitor and tiotropium or derivative thereof for treating obstructive airways and other inflammatory diseases
WO2006075748A1 (ja) * 2005-01-17 2006-07-20 Santen Pharmaceutical Co., Ltd. アレルギー性結膜疾患治療剤
CA2626612A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
RS53461B (en) 2006-07-05 2014-12-31 Takeda Gmbh COMBINATION OF HMG-COA REDUCTASE INHIBITOR OR SIMVASTATIN WITH PHOSPHODIESTERASE 4 INHIBITOR AS A ROFLUMILAST FOR THE TREATMENT OF INFLAMMATORY PULMONARY DISEASES
WO2010043676A1 (en) * 2008-10-17 2010-04-22 Boehringer Ingelheim International Gmbh Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (pi3-kinases) inhibitor
EP2507244B1 (en) 2009-12-04 2014-11-05 Nerviano Medical Sciences S.r.l. Tricyclopyrazole derivatives
WO2013084182A1 (en) 2011-12-08 2013-06-13 Glenmark Pharmaceuticals S.A. Pharmaceutical composition that includes a pde4 enzyme inhibitor and an analgesic agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697532A (en) * 1970-08-12 1972-10-10 Squibb & Sons Inc 5-methyldipyrazolo {8 3,4-b;3{40 ,4{40 -d{9 {0 pyridin-3(2h)-ones
BR9406946A (pt) * 1993-07-06 1996-08-06 Pfizer Tetra-hidro-pirazolpiridinas bicíclicas
CA2143143A1 (en) * 1994-03-08 1995-09-09 Toshihiko Tanaka 3-phenylpyrrolidine derivatives

Also Published As

Publication number Publication date
PL314459A1 (en) 1996-12-09
LV11620B (en) 1997-04-20
JP3107827B2 (ja) 2000-11-13
BR9602627A (pt) 1998-09-01
NO962320D0 (no) 1996-06-05
EP0837860B1 (en) 2002-03-20
IS4350A (is) 1996-12-07
DK0837860T3 (da) 2002-05-27
MA23893A1 (fr) 1996-12-31
SG54341A1 (en) 1998-11-16
CO4700460A1 (es) 1998-12-29
PT837860E (pt) 2002-07-31
SA96170065B1 (ar) 2005-12-21
HUP9601541A2 (en) 1997-02-28
IL118485A (en) 2000-02-17
NO962320L (no) 1996-12-09
CZ162696A3 (en) 1997-01-15
YU49346B (sh) 2005-07-19
CZ287251B6 (en) 2000-10-11
SI9600186A (en) 1997-04-30
CA2223624C (en) 2001-02-20
KR100191972B1 (ko) 1999-06-15
DZ2044A1 (fr) 2002-07-21
IS1913B (is) 2004-02-03
HRP960268B1 (en) 2002-12-31
LV11620A (lv) 1996-12-20
JPH10510242A (ja) 1998-10-06
EP0837860A1 (en) 1998-04-29
RO115881B1 (ro) 2000-07-28
HUP9601541A3 (en) 1997-05-28
CA2223624A1 (en) 1996-12-12
RU2161158C2 (ru) 2000-12-27
HRP960268A2 (en) 1997-08-31
PL184195B1 (pl) 2002-09-30
FI974434A (fi) 1997-12-05
AU694871B2 (en) 1998-07-30
TNSN96083A1 (fr) 2005-03-15
SK282167B6 (sk) 2001-11-06
IL118485A0 (en) 1996-09-12
AU5477396A (en) 1996-12-19
KR100225719B1 (en) 1999-10-15
ATE214700T1 (de) 2002-04-15
CN1061044C (zh) 2001-01-24
DE69525978D1 (de) 2002-04-25
FI114097B (fi) 2004-08-13
MY116527A (en) 2004-02-28
YU34696A (sh) 1999-07-28
HU9601541D0 (en) 1996-07-29
NZ286734A (en) 1998-02-26
WO1996039408A1 (en) 1996-12-12
AR002745A1 (es) 1998-04-29
CN1142499A (zh) 1997-02-12
MX9709897A (es) 1998-03-31
DE69525978T2 (de) 2002-12-19
BG62568B1 (bg) 2000-02-29
NO306256B1 (no) 1999-10-11
ES2172583T3 (es) 2002-10-01
TW460469B (en) 2001-10-21
BG100640A (bg) 1997-03-31
US6004974A (en) 1999-12-21
SK71896A3 (en) 1997-05-07
OA10458A (en) 2002-03-27
TR199600482A1 (tr) 1997-03-21
KR970003440A (ko) 1997-01-28
AP609A (en) 1997-09-03
AP9600806A0 (en) 1996-07-31

Similar Documents

Publication Publication Date Title
DE69509928D1 (de) Verbesserungen an Verriegelungsringen
ZA942570B (en) 1,5 benzodiazepine derivatives
FI953489A0 (fi) 2,6-diaminopuriinijohdannaisia
ID19599A (id) Turunan diamino-1,3,5-triazina tersubtitusi
FI954893A0 (fi) Näppäimistölukon aktivointi
FI974434A (fi) Trisyklisiä 5,6-dihydro-9H-pyratsolo(3,4-c)-1,2,4,-triatsolo(4,3-alfapidiinejä
NO991831D0 (no) Substituerte tricykliske forbindelser
ITTO910865A1 (it) Composti triciclici.
LV12207A (lv) Tricikliski savienojumi
AP9400657A0 (en) 1,5 benzodiazepine derivatives
FI913182A (fi) Tricykliska foereningar innehaollande heteroatomer.
IT1284701B1 (it) Serratura perfezionata
DK174891A (da) Benzodiazepinderivater
FI931451A0 (fi) 7-oxo-7h-pyrido(1,2,3-de)(1,4)bensoxazin-6-karboxylsyror och -estrar
DE59703521D1 (de) Gemische mit 1,1,1,3,3-pentafluorbutan
DE59607886D1 (de) Wegfahrsperre
FI891099A0 (fi) Tricykliska aminderivat.
FI950215A (fi) Trisykliset kefeemisulfonit
NO962931D0 (no) N,N-Dietyl-8,8-dipropyl-2-azaspiro[4,5Ådecan-2-propanamindimaleat
DE69519291D1 (de) Kombinationsschloss
BR9510036A (pt) Derivados de 1,3,4-oxadiazina
NO944024D0 (no) 1,2-dihydro-2-okso-pyridin
NO973317D0 (no) Dörlås
NO942212D0 (no) 13,14-dihydro-PGF2
NO943791D0 (no) 1,2-dihydro-2-okso-3-metylsulfonylaminometylpyridin